反応式
CC1C=CC=C2C=1C(=O)N(C1C=CC=CC=1)C(C(NC1N=CN=C3C=1N=CN3)CC)=N2.O=C1CCC(=O)N1OC(=O)C(NC(OCC1C=CC=CC=1)=O)COC(C)(C)C.O=C1CCC(=O)N1OC(=O)C(NC(OCC1C=CC=CC=1)=O)CC.[NH2:84][C:85]1[N:93]=[C:92]2[C:88]([NH:89][CH:90]=[N:91]2)=[C:87](Br)[N:86]=1.BrC1N=CN=C2C=1NC=N2.NC1N=C2C(N=CN2)=C([NH:115][CH:116]([C:123]2[N:132]([C:133]3[CH:138]=[CH:137][CH:136]=[CH:135][CH:134]=3)[C:131](=[O:139])[C:130]3[C:125](=[CH:126][CH:127]=[CH:128][C:129]=3[CH3:140])[N:124]=2)[CH2:117][O:118]C(C)(C)C)N=1>FC(F)(F)C(O)=O>[NH2:84][C:85]1[N:93]=[C:92]2[C:88]([N:89]=[CH:90][NH:91]2)=[C:87]([NH:115][CH:116]([C:123]2[N:132]([C:133]3[CH:134]=[CH:135][CH:136]=[CH:137][CH:138]=3)[C:131](=[O:139])[C:130]3[C:125](=[CH:126][CH:127]=[CH:128][C:129]=3[CH3:140])[N:124]=2)[CH2:117][OH:118])[N:86]=1参加物
8
反応物 6
生成物 1
試薬・触媒・溶媒 1
実験手順
Compound 68 was prepared using the general procedure described above with respect to compound 14, but 2-benzyloxycarbonylamino-3-tert-butoxy-propionic acid 2,5-dioxo-pyrrolidin-1-yl ester was substituted for 2-benzyloxycarbonylaminobutyric acid 2,5-dioxo-pyrrolidin-1-yl ester in step B, and 2-amino-6-bromopurine was substituted for 6-bromopurine in step D. The obtained 2-[1-(2-amino-9H-purin-6-ylamino) -2-tert-butoxy-ethyl]-5-methyl-3-phenyl-3H-quinazolin-4-one was then dissolved in trifluoroacetic acid and allowed to stir at ambient temperature for 5 hours. Purification by LC provided the product 68 as a white solid. MS (ES): m/z 429 (M+H), 215, 206, 151. Compound 68 is shown below.
後処理
- customCompound 68 was prepared
- customPurification by LC
出典と根拠
- ORDレコード
- ord-01a2d5fea9a84168898b2660165e6542
- 出典データセット
- uspto-grants-2015_03
- 特許番号
- US08980901B2
関連ノート
読み込み中…